Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Heartland Hematology Oncology Associates, Incorporated
mi
from
Kansas City, MO
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Heartland Hematology Oncology Associates, Incorporated
mi
from
Kansas City, MO
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Research Medical Center
mi
from
Kansas City, MO
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Research Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Saint Luke's East - Lee's Summit
mi
from
Lee's Summit, MO
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Saint Luke's East - Lee's Summit
mi
from
Lee's Summit, MO
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Liberty Radiation Oncology Center
mi
from
Liberty, MO
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Liberty Radiation Oncology Center
mi
from
Liberty, MO
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Heartland Regional Medical Center
mi
from
Saint Joseph, MO
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Heartland Regional Medical Center
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Cancer Research for the Ozarks NCORP
mi
from
Springfield, MO
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Cancer Research for the Ozarks NCORP
mi
from
Springfield, MO
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Cox Medical Center South
mi
from
Springfield, MO
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Cox Medical Center South
mi
from
Springfield, MO
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Cheshire Medical Center-Dartmouth-Hitchcock Keene
mi
from
Keene, NH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Cheshire Medical Center-Dartmouth-Hitchcock Keene
mi
from
Keene, NH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Cooper Hospital University Medical Center
mi
from
Camden, NJ
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Cooper Hospital University Medical Center
mi
from
Camden, NJ
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Virtua Memorial
mi
from
Mount Holly, NJ
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Virtua Memorial
mi
from
Mount Holly, NJ
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Sparta Cancer Treatment Center
mi
from
Sparta, NJ
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Sparta Cancer Treatment Center
mi
from
Sparta, NJ
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Virtua Voorhees
mi
from
Voorhees, NJ
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Virtua Voorhees
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Highland Hospital
mi
from
Rochester, NY
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Highland Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Aultman Health Foundation
mi
from
Canton, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Aultman Health Foundation
mi
from
Canton, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Samaritan North Health Center
mi
from
Dayton, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Samaritan North Health Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
University Pointe
mi
from
West Chester, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
University Pointe
mi
from
West Chester, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Salem Hospital
mi
from
Salem, OR
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Salem Hospital
mi
from
Salem, OR
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Delaware County Memorial Hospital
mi
from
Drexel Hill, PA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Delaware County Memorial Hospital
mi
from
Drexel Hill, PA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Northeast Radiation Oncology Center
mi
from
Dunmore, PA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Northeast Radiation Oncology Center
mi
from
Dunmore, PA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Adams Cancer Center
mi
from
Gettysburg, PA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Adams Cancer Center
mi
from
Gettysburg, PA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Cherry Tree Cancer Center
mi
from
Hanover, PA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Cherry Tree Cancer Center
mi
from
Hanover, PA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Upper Delaware Valley Cancer Center
mi
from
Milford, PA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Upper Delaware Valley Cancer Center
mi
from
Milford, PA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
WellSpan Health-York Hospital
mi
from
York, PA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
WellSpan Health-York Hospital
mi
from
York, PA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Saint Francis Hospital
mi
from
Greenville, SC
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Saint Francis Hospital
mi
from
Greenville, SC
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Thompson Cancer Survival Center West
mi
from
Knoxville, TN
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Thompson Cancer Survival Center West
mi
from
Knoxville, TN
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Thompson Cancer Survival Center at Methodist
mi
from
Oak Ridge, TN
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Thompson Cancer Survival Center at Methodist
mi
from
Oak Ridge, TN
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
University of Texas Medical Branch
mi
from
Galveston, TX
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Covenant Medical Center-Lakeside
mi
from
Lubbock, TX
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Covenant Medical Center-Lakeside
mi
from
Lubbock, TX
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Sandra L. Maxwell Cancer Center
mi
from
Cedar City, UT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Sandra L. Maxwell Cancer Center
mi
from
Cedar City, UT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Logan Regional Hospital
mi
from
Logan, UT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Logan Regional Hospital
mi
from
Logan, UT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Cottonwood Hospital Medical Center
mi
from
Murray, UT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Cottonwood Hospital Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
McKay-Dee Hospital Center
mi
from
Ogden, UT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
McKay-Dee Hospital Center
mi
from
Ogden, UT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Utah Valley Regional Medical Center
mi
from
Provo, UT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Utah Valley Regional Medical Center
mi
from
Provo, UT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Dixie Medical Center Regional Cancer Center
mi
from
Saint George, UT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Dixie Medical Center Regional Cancer Center
mi
from
Saint George, UT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Intermountain Health Care
mi
from
Salt Lake City, UT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Intermountain Health Care
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Utah Cancer Specialists-Salt Lake City
mi
from
Salt Lake City, UT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Utah Cancer Specialists-Salt Lake City
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
LDS Hospital
mi
from
Salt Lake City, UT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
LDS Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
University of Vermont Medical Center
mi
from
Burlington, VT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
University of Vermont Medical Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
University of Vermont College of Medicine
mi
from
Burlington, VT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
University of Vermont College of Medicine
mi
from
Burlington, VT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Norris Cotton Cancer Center-North
mi
from
Saint Johnsbury, VT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Norris Cotton Cancer Center-North
mi
from
Saint Johnsbury, VT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Wheeling Hospital/Schiffler Cancer Center
mi
from
Wheeling, WV
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Wheeling Hospital/Schiffler Cancer Center
mi
from
Wheeling, WV
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Green Bay Oncology at Saint Vincent Hospital
mi
from
Green Bay, WI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Green Bay Oncology at Saint Vincent Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials